Related Experiment Video
Updated: Mar 10, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.2K
Boost Approaches in Patients Undergoing Postoperative Radiotherapy.
Abigail Pepin1, Neil D Almeida2, Simon Fung-Kee-Fung2
1Department of Radiation Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Journal of Surgical Oncology
|March 9, 2026
Summary
This review examines radiation tumor bed boost techniques for early-stage breast cancer. It summarizes current literature on indications, outcomes, and planning for concurrent boost radiotherapy to reduce treatment time.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Breast conservation surgery is a common treatment for early-stage breast cancer.
- Adjuvant radiotherapy is frequently used to minimize the risk of ipsilateral breast tumor recurrence.
- Sequential boost techniques have historically demonstrated favorable outcomes in reducing local recurrence and maintaining cosmetic results.
Purpose of the Study:
- To review the current literature on radiation tumor bed boost for early-stage breast cancer.
- To summarize indications, outcomes, and treatment planning considerations for concurrent tumor bed boost.
- To explore the shift towards concurrent boost techniques to shorten radiation treatment duration.
Main Methods:
- Focused literature review of studies on radiation tumor bed boost in early-stage breast cancer.
- Analysis of historical trials and recent research on sequential versus concurrent boost techniques.
- Synthesis of data regarding patient selection, radiation delivery, and outcomes.
Main Results:
- Historical sequential boost techniques show reduced local recurrence and acceptable cosmetic outcomes.
- Renewed interest exists in concurrent tumor bed boost to decrease the overall number of radiation treatments.
- The review consolidates information on the clinical application of tumor bed boost strategies.
Conclusions:
- Radiation tumor bed boost is a relevant strategy for early-stage breast cancer management.
- Concurrent boost offers a potential method to shorten radiotherapy duration while maintaining efficacy.
- Further research and standardized guidelines are important for optimizing tumor bed boost application.
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
561
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
561
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K

